Clinical Trials Browser

Recruiting × Hodgkin Disease × Carmustine × Clear all

NCT04871607 2025-12-04

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

Phase 2 Recruiting

Hodgkin Disease

NCT06915246 2025-04-10

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Phase 2 Recruiting

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin